Bandingkan Harga & Kinerja Jaya Real Property Tbk. (JRPT) vs Brigit Biofarmaka Teknologi Tbk. (OBAT)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Jaya Real Property Tbk. dan Brigit Biofarmaka Teknologi Tbk.: Jaya Real Property Tbk. diperdagangkan di Rp1.080 (kapitalisasi pasar 13,94 T, volume 24 jam 2,6 jt), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp248 (kapitalisasi pasar 167,37 M, volume 24 jam 96,7 rb). Perbedaan utamanya: Jaya Real Property Tbk. jauh lebih besar — sekitar 83,3× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Jaya Real Property Tbk. lebih aktif diperdagangkan (2,6 jt vs 96,7 rb). Mana yang lebih baik tergantung tujuan investasimu.
| JRPT | OBAT | |
|---|---|---|
Kapitalisasi Pasar | 13,94 T | 167,37 M |
Volume | 2,6 jt | 96,7 rb |
Lot | 26,04 rb | 967 |
Perputaran | 2,81 M | 23,82 jt |
Harga Rata-rata | 1.079,74 | 246,34 |
Nilai Transaksi | 2,81 M | 23,82 jt |
Harga Ekuilibrium Indikatif | 1.080 | 248 |
Volume Ekuilibrium Indikatif | 24,02 rb | 41 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Jaya Real Property Tbk.
PT Jaya Real Property Tbk (the Company) was established under Domestic Investment Law on May 25, 1979, based on the notarial deed No. 36 of Hobropoerwanto, S.H., at that time a notary in Jakarta, and amended with notarial deed No. 14 of the same notary as of December 6, 1979.. Jaya Real Property is the largest property company (in terms of market capitalization) listed on the JSX. It is a wholly owned subsidiary of PT Pembangunan Jaya (the Jaya Group), which is the oldest established property developer.
Selengkapnya di halaman JRPT →Tentang Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →
